Pharmaceutical Evaluation & Policy
The Pharmaceutical Sciences M.S. and Ph.D. programs offer a curriculum with a concentration in Pharmaceutical Evaluation and Policy (PEP) to meet the training needs of persons with business, science, and health care backgrounds wishing to acquire the research skills in pharmaceutical evaluation and pharmacoeconomics, health outcomes assessment, policy analyses, pharmacoepidemiology, and social behavioral research in pharmacy.
Pharmaceuticals are increasingly being used to cure, treat, manage, or provide relief for many human afflictions, however, issues of financing, efficiency, access, adherence, and safety of pharmaceuticals continue to challenge the health care systems of the world. The goal of the Pharmaceutical Evaluation and Policy (PEP) graduate program is to advance and disseminate knowledge about the delivery and value of pharmaceutical products and services and contribute to health policy and program development that benefits society. Using a multidisciplinary approach, individuals in the program will acquire the abilities to conduct research that evaluates the value of pharmaceutical products, services, and financing systems. The program will prepare individuals for positions in academia and managerial positions in the pharmaceutical industry, contract research organizations, managed care organizations, and government agencies.
The Pharmaceutical Evaluation and Policy Division works closely with state, national, and international leaders to help guide policy evaluation and development as well as to develop scientific guidances and to conduct rigorous original research. Our program utilizes an applied approach where graduate trainees gain strong analytic skills that have applications in Pharmacoeconomics, Comparative Effectiveness Research, Epidemiology, and Policy Analysis. Our division has developed a health policy fellowship program where graduate student trainees can gain leadership and real world health policy research experiences.